Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of CDK inhibitor for the treatment of glioma

Use of CDK inhibitor for the treatment of glioma

US Patent 8946226 · Granted Feb 3, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted indazole derivatives active as kinase inhibitiors2019
Substituted indazole derivatives active as kinase inhibitiors2018
Substituted indazole derivatives active as kinase inhibitiors2017
Substituted indazole derivatives active as kinase inhibitors2016
Therapeutic combination comprising a Cdc7 inhibitor and an anti-neoplastic agent2015
Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent2015
CDK inhibitor for the treatment of mesothelioma2014
Use of kinase inhibitor for the treatment of thymoma2013
Therapeutic combination comprising a CDKS inhibitor and an antineoplastic agent2013
Therapeutic combination comprising a CDKS inhibitor and an antineoplastic agent2013
Combinations comprising a CDK inhibitor and a growth factor antibody or anti-mit2011
Anthracycline glycosides2001